Non-food Packaging
Pharmaceutical Glass Packaging Market

Pharmaceutical Glass Packaging Market Size, Share, Trends, Growth, and Forecasts for 2025 - 2032

Pharmaceutical Glass Packaging Market by Material (Type I, Type II, Type III), by Product Type (Vials, Bottles, Cartridges and Syringes, Ampoules), by Drug Type (Generic, Branded, Biologic), and Regional Analysis for 2025 - 2032

ID: PMRREP3778

September 2025

189 Pages

Author : Sayali Mali

Packaging

Preview Segmentation

Pharmaceutical Glass Packaging Market Size and Trends

The pharmaceutical glass packaging market size is likely to be valued at US$ 23.0 Bn in 2025 and is estimated to reach US$ 44.3 Bn in 2032, growing at a CAGR of 9.8% during the forecast period 2025-2032. The pharmaceutical glass packaging market growth is driven by expansion of biologics, vaccines, and generic injectables. In addition, increasing demand for high-quality, sterile, and ready-to-use containers that ensure drug stability and patient safety is spurring growth.

Companies are responding with capacity expansions, strategic acquisitions, and product developments. Competition is intense with global leaders aiming to provide differentiated glass solutions that combine durability and regulatory compliance.

global-pharmaceutical-glass-packaging-market-size-2025–2032

Key Industry Highlights

Leading Product Type: Bottles hold nearly 36.5% share in 2025, backed by their versatility across liquid formulations and ability to support novel dosing systems.
Dominant Drug Type: Generic drugs, approximately 71.3% of the pharmaceutical glass packaging market share in 2025, as they are produced in high volumes and require standardized containers.
Leading Region: North America with around 37.2% share in 2025, due to the near-shoring of glass production and increasing adoption of prefillable syringes.
Fastest-growing Region: Europe, owing to rising demand for biologics and specialty injectables as well as investments in eco-friendly glass manufacturing technologies.
New Product Launch: Nipro PharmaPackaging introduced its new Direct-to-Fill (D2F) glass vials powered by Stevanato Group’s novel EZ-fill technology. These vials are washed, depyrogenated, packaged in nest and tub formats, and sterilized.

Global Market Attribute	Key Insights
Pharmaceutical Glass Packaging Market Size (2025E)	US$ 23.0 Bn
Market Value Forecast (2032F)	US$ 44.3 Bn
Projected Growth (CAGR 2025 to 2032)	9.8%
Historical Market Growth (CAGR 2019 to 2024)	8.9%

Market Dynamics

Driver - Growth of Generic Injectables Increases Demand for Superior Glass Containers

Increasing use of generic injectable drugs is fueling demand for pharmaceutical glass packaging as these drugs require high-quality containers for mass production and distribution. Injectable forms demand vials and prefilled syringes that can maintain sterility and stability. In India and China, where generic injectables form a key part of the pharmaceutical output, manufacturers are investing in pre-sterilized glass vials to improve production.

Generic injectables also augment demand because of their fast market turnover and large-scale distribution requirements. Companies demand glass packaging that can handle high-volume filling lines without compromising on quality. The rise of biosimilar injectables is another factor. As patents for biologics expire, generic versions are entering the market, requiring the same high-spec glass used for original biologics to ensure drug stability.

Restraint - Weight Variation Compromises Dimensional Consistency and Breakage Resistance

Weight variation in glass production is a key issue as it affects dimensional consistency, breakage resistance, and fill-finish reliability. Even minor differences in wall thickness or total weight can lead to weak points in vials or bottles. It increases the risk of cracks or fractures during sterilization, transport, or high-speed filling. This makes manufacturers cautious, especially for sensitive biologics and injectable drugs, where any compromise in container integrity can lead to contamination or dosage errors.

The problem is evident in high-volume production of generic injectables, where automated lines require uniform glass to avoid stoppages or rejects. Facilities producing large batches of vials or bottles tend to experience high line downtime when weight variations lead to misalignment with closures, stoppers, or filling machines. A few contract manufacturers in India and China, for example, have reported operational slowdowns due to inconsistent vial weights, prompting them to seek suppliers with strict quality controls.

Opportunity - Precision Dosing and Validated Containment Systems Improve Regulatory Compliance

The rising emphasis on product safety in healthcare is creating new opportunities for pharmaceutical glass packaging manufacturers. This is because premium glass materials reduce contamination risk and maintain drug stability. These features appeal to manufacturers who must comply with strict regulatory standards in the U.S., Europe, and parts of Asia. Efficacy concerns are also spurring demand for precision dosing and validated containment systems.

Ready-to-use (RTU) vials and prefilled syringes allow accurate and consistent drug delivery, which is important for GLP-1 therapies, oncology treatments, and vaccines. Patient convenience is another key driver. Modern glass packaging now supports features such as prefilled syringes, metered-dose bottles, and easy-to-open closures. These make administration convenient at home or in clinical settings.

Get Your CustomizationGet Your Customization

Category-wise Analysis

Product Type Insights

By product type, the market is divided into vials, bottles, cartridges and syringes, and ampoules. Among these, pharmaceutical glass bottles are speculated to account for nearly 36.5% of share in 2025 as they provide the most versatile containment solution for liquids, suspensions, and injectables. These can be produced in a wide range of sizes, from a few milliliters for potent drugs to hundreds of milliliters for oral liquids. It makes them suitable for hospitals, pharmacies, and home use. This versatility propels consistent demand across multiple drug categories.

Pharmaceutical glass vials are seeing considerable growth as they are the preferred format for injectables and high-value biologics, which are expanding steadily in global healthcare. Vials are compact, easy to store, and compatible with automated filling lines. These make them ideal for vaccines, monoclonal antibodies, and GLP-1 therapies. Recent launches of new biologics and personalized medicines have accelerated this trend, especially in the U.S. and Europe. Also, the expansion of cold-chain logistics and high-value drug distribution is augmenting demand.

Drug Type Insights

Based on drug type, the market is trifurcated into generic, branded, and biologic. Out of these, generic will likely hold around 71.3% of share in 2025 as they require large-scale and cost-efficient production for oral liquids, injectables, and suspensions. Generics are produced in high volumes, making bottles and vials the default choice for standardized packaging. The shift toward biosimilar generics and injectable generics is also boosting glass demand. Cost and efficiency pressures further make generics a key driver for standardized glass packaging.

Biologics exhibit steady growth because these drugs are sensitive and require specialized as well as high-quality containers. Standard glass cannot always ensure chemical inertness or prevent interaction with the drug. Hence, manufacturers are turning to novel borosilicate glass or aluminosilicate vials that resist delamination and maintain product stability. Another factor is the rise of prefilled and ready-to-use (RTU) formats, which reduce contamination risk and speed up manufacturing for biologics.

global-pharmaceutical-glass-packaging-market-outlook-by-product-type-2025–2032

Regional Insights

North America Pharmaceutical Glass Packaging Market Trends - New Domestic Facilities Ensure Steady Supply of Prefillable Syringes and Vials

In 2025, North America is predicted to account for approximately 37.2% of share as pharmaceutical glass packaging is shifting toward local production because drug makers want to reduce supply chain risks. A key example is SCHOTT’s new facility in Wilson, North Carolina, announced in 2024. The plant will produce prefillable syringes and vials for vaccines, biologics, and GLP-1 drugs, ensuring U.S. pharma companies have a steady domestic supply.

Corning is also playing a major role in the U.S. pharmaceutical glass packaging market with its Valor and Viridian glass technologies. These are designed to reduce breakage and delamination in high-speed filling lines. These products are already being used by leading pharma companies, often in partnership with West Pharmaceutical Services. The focus is no longer just on glass, but on complete container-closure systems that can handle sensitive biologics.

Europe Pharmaceutical Glass Packaging Market Trends - Focus on High-margin Injectable Packaging Strengthens Supplier Positioning

In Europe, pharmaceutical glass packaging is influenced by strict quality and safety rules from the European Medicines Agency (EMA) along with the EU’s powerful sustainability agenda. Most companies now focus on producing high-quality borosilicate glass for injectables while also cutting carbon emissions through electric furnaces and high recycling rates. Since glass recycling levels in Europe are already among the highest worldwide, packaging firms are also investing in lightweight glass and eco-friendly production methods.

Mergers and acquisitions are changing the competitive map. Gerresheimer bought Bormioli Pharma in 2024 to expand its molded glass portfolio. But in 2025, it signaled plans to shift its focus more toward high-margin injectable packaging. At the same time, SGD Pharma recently acquired Alphial in Italy, adding more ampoule, vial, and ready-to-use production capacity in Europe. These strategies show how suppliers are consolidating to strengthen their positions in premium segments.

Asia Pacific Pharmaceutical Glass Packaging Market Trends - New Production Lines Support Local Biotech Companies and Premium Vial Supply

Drug makers in Asia Pacific are no longer satisfied with basic glass vials and are increasingly demanding ready-to-use formats that save time and reduce contamination risks. This change is most visible in India and China, where various contract manufacturers serve global pharma companies. Several companies are broadening their presence in Asia Pacific. Nipro upgraded its furnace in Meerut, India, to produce high-quality glass tubing for premium vials and syringes.

Schott has also invested in new production lines in China to supply local biotech firms. Corning is promoting its Valor glass across Asia Pacific to tackle problems such as delamination and breakage during high-speed filling. Sustainability is also starting to influence the regional market. With rising energy costs and strict local regulations, manufacturers are looking at efficient furnaces, lightweight glass, and high recycling use.

global-pharmaceutical-glass-packaging-market-outlook-by-region-2025–2032

Request Free sampleRequest Free sample

Competitive Landscape

The pharmaceutical glass packaging market is dominated by a few vertically integrated specialists that control important steps from tubing to ready-to-use (RTU) formats. Leading players compete on fill-finish efficiency and quality attributes such as low particle load, chemical durability, and break-resistance. Mergers and acquisitions are also influencing the market. In India and Europe, companies are upgrading capacity to support biologics and GLP-1 therapies. These moves show how competition is shifting from commodity glass to high-spec containers designed for modern biologics.

Key Industry Developments

In August 2025, SCHOTT became the first in India to locally produce high-precision glass tubing for cartridges and syringes in its manufacturing facility in Gujarat. This expansion addresses the rising demand for GLP-1-based injectables such as semaglutide used in diabetes and weight management.
In January 2025, SGD Pharma declared that it would exhibit a wide range of products and services, including its platform Sealian, at Pharmapack. Sealian platform is an internal treatment for glass vials that creates a barrier coating to preserve the integrity of the sensitive therapeutic product inside.

Companies Covered in Pharmaceutical Glass Packaging Market

Amcor plc
AptarGroup, Inc.
Becton, Dickinson, and Company
Schott AG
Gerresheimer AG
Drug Plastics Group
West Pharmaceutical Services, Inc.
SGD Pharma
Owens Illinois, Inc.
Berry Global, Inc.
Vetter Pharma International
CCL Industries, Inc.
Comar, LLC
International Paper
WestRock Company
Others

Frequently Asked Questions

The pharmaceutical glass packaging market is projected to reach US$ 23.0 Bn in 2025.

Rising demand for biologics and surging focus on drug safety are the key market drivers.

The pharmaceutical glass packaging market is poised to witness a CAGR of 9.8% from 2025 to 2032.

Shift toward RTU vials and investments in high-speed fill-finish systems are the key market opportunities.

Amcor plc, AptarGroup, Inc., and Becton, Dickinson, and Company are a few key market players.

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Executive Summary
1. Global Pharmaceutical Glass Packaging Market Snapshot, 2025 and 2032
2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Challenges
  5. Key Trends
3. COVID-19 Impact Analysis
4. Forecast Factors - Relevance and Impact
Value Chain Analysis
1. Supply Chain Analysis
2. List of Key Market Players
Value Added Insights
1. PESTLE Analysis
  1. Porter’s Five Force Analysis
Price Trend Analysis, 2019 - 2032
1. Pricing Analysis, By Material
2. Key Factors Impacting Prices, By Product Type
Global Pharmaceutical Glass Packaging Market Outlook
1. 1. Market Size (US$ Bn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Bn) Analysis and Forecast
  1. Historical Market Size (US$ Bn) Analysis, 2019-2024
  2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
3. Global Pharmaceutical Glass Packaging Market Outlook: Material
  1. Historical Market Size (US$ Bn) Analysis, By Material, 2019-2024
  2. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
    1. Type I
    2. Type II
    3. Type III
  3. Market Attractiveness Analysis: Material
4. Global Pharmaceutical Glass Packaging Market Outlook: Product Type
  1. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2024
  2. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    1. Vials
    2. Bottles
    3. Cartridges and Syringes
    4. Ampoules
  3. Market Attractiveness Analysis: Product Type
5. Global Pharmaceutical Glass Packaging Market Outlook: Drug Type
  1. Historical Market Size (US$ Bn) Analysis, By Drug Type, 2019-2024
  2. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025-2032
    1. Generic
    2. Branded
    3. Biologic
  3. Market Attractiveness Analysis: Drug Type
Global Pharmaceutical Glass Packaging Market Outlook: Region
1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
3. Market Attractiveness Analysis: Region
North America Pharmaceutical Glass Packaging Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Material
  3. By Product Type
  4. By Drug Type
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  1. U.S.
  2. Canada
3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
  1. Type I
  2. Type II
  3. Type III
4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
  1. Vials
  2. Bottles
  3. Cartridges and Syringes
  4. Ampoules
5. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025-2032
  1. Generic
  2. Branded
  3. Biologic
6. Market Attractiveness Analysis
Europe Pharmaceutical Glass Packaging Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Material
  3. By Product Type
  4. By Drug Type
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
  1. Type I
  2. Type II
  3. Type III
4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
  1. Vials
  2. Bottles
  3. Cartridges and Syringes
  4. Ampoules
5. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025-2032
  1. Generic
  2. Branded
  3. Biologic
6. Market Attractiveness Analysis
East Asia Pharmaceutical Glass Packaging Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Material
  3. By Product Type
  4. By Drug Type
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  1. China
  2. Japan
  3. South Korea
3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
  1. Type I
  2. Type II
  3. Type III
4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
  1. Vials
  2. Bottles
  3. Cartridges and Syringes
  4. Ampoules
5. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025-2032
  1. Generic
  2. Branded
  3. Biologic
6. Market Attractiveness Analysis
South Asia & Oceania Pharmaceutical Glass Packaging Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Material
  3. By Product Type
  4. By Drug Type
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
  1. Type I
  2. Type II
  3. Type III
4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
  1. Vials
  2. Bottles
  3. Cartridges and Syringes
  4. Ampoules
5. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025-2032
  1. Generic
  2. Branded
  3. Biologic
6. Market Attractiveness Analysis
Latin America Pharmaceutical Glass Packaging Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Material
  3. By Product Type
  4. By Drug Type
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  1. Brazil
  2. Mexico
  3. Rest of Latin America
3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
  1. Type I
  2. Type II
  3. Type III
4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
  1. Vials
  2. Bottles
  3. Cartridges and Syringes
  4. Ampoules
5. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025-2032
  1. Generic
  2. Branded
  3. Biologic
6. Market Attractiveness Analysis
Middle East & Africa Pharmaceutical Glass Packaging Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Material
  3. By Product Type
  4. By Drug Type
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
  1. Type I
  2. Type II
  3. Type III
4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
  1. Vials
  2. Bottles
  3. Cartridges and Syringes
  4. Ampoules
5. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025-2032
  1. Generic
  2. Branded
  3. Biologic
6. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Amcor plc
    1. Overview
    2. Segments and Material
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. AptarGroup, Inc.
  3. Becton, Dickinson, and Company
  4. Schott AG
  5. Gerresheimer AG
  6. Drug Plastics Group
  7. West Pharmaceutical Services, Inc.
  8. SGD Pharma
  9. Owens Illinois, Inc.
  10. Berry Global, Inc.
  11. Vetter Pharma International
  12. CCL Industries, Inc.
  13. Comar, LLC
  14. International Paper
  15. WestRock Company
  16. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Report Attribute	Details
Historical Data/Actuals	2019 – 2024
Forecast Period	2025 – 2032
Market Analysis	Value: US$ Bn/Mn, Volume: As Applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Latin America Middle East and Africa
Segmental Coverage	Material Product Type Drug Type Region
Competitive Analysis	Amcor plc AptarGroup, Inc. Becton, Dickinson, and Company Schott AG Gerresheimer AG Drug Plastics Group West Pharmaceutical Services, Inc. SGD Pharma Owens Illinois, Inc. Berry Global, Inc. Vetter Pharma International CCL Industries, Inc. Comar, LLC International Paper WestRock Company Others
Report Highlights	Market Forecast and Trends Competitive Intelligence and Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis Future Opportunities and Revenue Pockets Market Analysis Tools
Customization and Pricing	Available upon request

Report Attribute	Details
Historical Data/Actuals	2019 – 2024
Forecast Period	2025 – 2032
Market Analysis	Value: US$ Bn/Mn, Volume: As Applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Latin America Middle East and Africa
Segmental Coverage	Material Product Type Drug Type Region
Competitive Analysis	Amcor plc AptarGroup, Inc. Becton, Dickinson, and Company Schott AG Gerresheimer AG Drug Plastics Group West Pharmaceutical Services, Inc. SGD Pharma Owens Illinois, Inc. Berry Global, Inc. Vetter Pharma International CCL Industries, Inc. Comar, LLC International Paper WestRock Company Others
Report Highlights	Market Forecast and Trends Competitive Intelligence and Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis Future Opportunities and Revenue Pockets Market Analysis Tools
Customization and Pricing	Available upon request

Pharmaceutical Glass Packaging Market Size, Share, Trends, Growth, and Forecasts for 2025 - 2032

Pharmaceutical Glass Packaging Market by Material (Type I, Type II, Type III), by Product Type (Vials, Bottles, Cartridges and Syringes, Ampoules), by Drug Type (Generic, Branded, Biologic), and Regional Analysis for 2025 - 2032